These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 12712058

  • 1. Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy.
    Casper RC, Fleisher BE, Lee-Ancajas JC, Gilles A, Gaylor E, DeBattista A, Hoyme HE.
    J Pediatr; 2003 Apr; 142(4):402-8. PubMed ID: 12712058
    [Abstract] [Full Text] [Related]

  • 2. Neonatal and childhood neurodevelopmental, health and educational outcomes of children exposed to antidepressants and maternal depression during pregnancy: protocol for a retrospective population-based cohort study using linked administrative data.
    Singal D, Brownell M, Chateau D, Ruth C, Katz LY.
    BMJ Open; 2016 Nov 29; 6(11):e013293. PubMed ID: 27899401
    [Abstract] [Full Text] [Related]

  • 3. Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression.
    Nulman I, Koren G, Rovet J, Barrera M, Pulver A, Streiner D, Feldman B.
    Am J Psychiatry; 2012 Nov 29; 169(11):1165-74. PubMed ID: 23128923
    [Abstract] [Full Text] [Related]

  • 4. Length of prenatal exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants: effects on neonatal adaptation and psychomotor development.
    Casper RC, Gilles AA, Fleisher BE, Baran J, Enns G, Lazzeroni LC.
    Psychopharmacology (Berl); 2011 Sep 29; 217(2):211-9. PubMed ID: 21499702
    [Abstract] [Full Text] [Related]

  • 5. Association of Selective Serotonin Reuptake Inhibitor Exposure During Pregnancy With Speech, Scholastic, and Motor Disorders in Offspring.
    Brown AS, Gyllenberg D, Malm H, McKeague IW, Hinkka-Yli-Salomäki S, Artama M, Gissler M, Cheslack-Postava K, Weissman MM, Gingrich JA, Sourander A.
    JAMA Psychiatry; 2016 Nov 01; 73(11):1163-1170. PubMed ID: 27732704
    [Abstract] [Full Text] [Related]

  • 6. Infant developmental outcomes following prenatal exposure to antidepressants, and maternal depressed mood and positive affect.
    Hanley GE, Brain U, Oberlander TF.
    Early Hum Dev; 2013 Aug 01; 89(8):519-24. PubMed ID: 23384962
    [Abstract] [Full Text] [Related]

  • 7. Infant and childhood neurodevelopmental outcomes following prenatal exposure to selective serotonin reuptake inhibitors: overview and design of a Finnish Register-Based Study (FinESSI).
    Malm H, Artama M, Brown AS, Gissler M, Gyllenberg D, Hinkka-Yli-Salomäki S, McKeague I, Sourander A.
    BMC Psychiatry; 2012 Dec 04; 12():217. PubMed ID: 23206294
    [Abstract] [Full Text] [Related]

  • 8. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
    Favrelière S, Nourrisson A, Jaafari N, Pérault Pochat MC.
    Encephale; 2010 Jun 04; 36 Suppl 2():D133-8. PubMed ID: 20513456
    [Abstract] [Full Text] [Related]

  • 9. Impact of prenatal exposure to serotonin reuptake inhibitors or maternal major depressive disorder on infant developmental outcomes.
    Santucci AK, Singer LT, Wisniewski SR, Luther JF, Eng HF, Dills JL, Sit DK, Hanusa BH, Wisner KL.
    J Clin Psychiatry; 2014 Oct 04; 75(10):1088-95. PubMed ID: 25373117
    [Abstract] [Full Text] [Related]

  • 10. Maternal use of selective serotonin reuptake inhibitors, fetal growth, and risk of adverse birth outcomes.
    El Marroun H, Jaddoe VW, Hudziak JJ, Roza SJ, Steegers EA, Hofman A, Verhulst FC, White TJ, Stricker BH, Tiemeier H.
    Arch Gen Psychiatry; 2012 Jul 04; 69(7):706-14. PubMed ID: 22393202
    [Abstract] [Full Text] [Related]

  • 11. [Use of SSRIs during pregnancy and possible consequences for the development of the child].
    van der Veere CN, Bos AF.
    Ned Tijdschr Geneeskd; 2007 Dec 29; 151(52):2873-4. PubMed ID: 18257430
    [Abstract] [Full Text] [Related]

  • 12. Major depressive disorder during pregnancy: Psychiatric medications have minimal effects on the fetus and infant yet development is compromised.
    Gustafsson HC, Goodman SH, Feng T, Choi J, Lee S, Newport DJ, Knight B, Pingeton B, Stowe ZN, Monk C.
    Dev Psychopathol; 2018 Aug 29; 30(3):773-785. PubMed ID: 30068426
    [Abstract] [Full Text] [Related]

  • 13. Effect of Time-Dependent Selective Serotonin Reuptake Inhibitor Antidepressants During Pregnancy on Behavioral, Emotional, and Social Development in Preschool-Aged Children.
    Lupattelli A, Wood M, Ystrom E, Skurtveit S, Handal M, Nordeng H.
    J Am Acad Child Adolesc Psychiatry; 2018 Mar 29; 57(3):200-208. PubMed ID: 29496129
    [Abstract] [Full Text] [Related]

  • 14. In Utero Antidepressants and Neurodevelopmental Outcomes in Kindergarteners.
    Singal D, Chateau D, Struck S, Lee JB, Dahl M, Derksen S, Katz LY, Ruth C, Hanlon-Dearman A, Brownell M.
    Pediatrics; 2020 May 29; 145(5):. PubMed ID: 32341177
    [Abstract] [Full Text] [Related]

  • 15. Intra-uterine exposure to selective serotonin reuptake inhibitors (SSRIs), maternal psychopathology, and neurodevelopment at age 2.5years - Results from the prospective cohort SMOK study.
    van der Veere CN, de Vries NKS, van Braeckel KNJA, Bos AF.
    Early Hum Dev; 2020 Aug 29; 147():105075. PubMed ID: 32504880
    [Abstract] [Full Text] [Related]

  • 16. Motor development in children prenatally exposed to selective serotonin reuptake inhibitors: a large population-based pregnancy cohort study.
    Handal M, Skurtveit S, Furu K, Hernandez-Diaz S, Skovlund E, Nystad W, Selmer R.
    BJOG; 2016 Nov 29; 123(12):1908-1917. PubMed ID: 26374234
    [Abstract] [Full Text] [Related]

  • 17. Neurodevelopment of children exposed in utero to antidepressant drugs.
    Nulman I, Rovet J, Stewart DE, Wolpin J, Gardner HA, Theis JG, Kulin N, Koren G.
    N Engl J Med; 1997 Jan 23; 336(4):258-62. PubMed ID: 8995088
    [Abstract] [Full Text] [Related]

  • 18. Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data.
    Oberlander TF, Warburton W, Misri S, Aghajanian J, Hertzman C.
    Arch Gen Psychiatry; 2006 Aug 23; 63(8):898-906. PubMed ID: 16894066
    [Abstract] [Full Text] [Related]

  • 19. Early morbidity and mortality following in utero exposure to selective serotonin reuptake inhibitors: a population-based study in Western Australia.
    Colvin L, Slack-Smith L, Stanley FJ, Bower C.
    CNS Drugs; 2012 Jul 01; 26(7):e1-14. PubMed ID: 22712699
    [Abstract] [Full Text] [Related]

  • 20. Infant neurodevelopment following in utero exposure to antidepressant medication.
    Austin MP, Karatas JC, Mishra P, Christl B, Kennedy D, Oei J.
    Acta Paediatr; 2013 Nov 01; 102(11):1054-9. PubMed ID: 23927695
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.